DOP2012000001A - Derivados de pirazoles, su preparacion y su aplicacion terapeutica - Google Patents

Derivados de pirazoles, su preparacion y su aplicacion terapeutica

Info

Publication number
DOP2012000001A
DOP2012000001A DO2012000001A DO2012000001A DOP2012000001A DO P2012000001 A DOP2012000001 A DO P2012000001A DO 2012000001 A DO2012000001 A DO 2012000001A DO 2012000001 A DO2012000001 A DO 2012000001A DO P2012000001 A DOP2012000001 A DO P2012000001A
Authority
DO
Dominican Republic
Prior art keywords
preparation
pirazoles
derivados
therapeutic application
application
Prior art date
Application number
DO2012000001A
Other languages
English (en)
Inventor
Michel Tabart
Pascal Desmazeau
Pierre-Yves Abecassis
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DOP2012000001A publication Critical patent/DOP2012000001A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere !os derivados de pirazoles de a fórmu!a general (!) en la que: en donde X representa cloro o flúor. Procedimiento de preparación y aplicación en terapéutica
DO2012000001A 2009-07-03 2012-01-02 Derivados de pirazoles, su preparacion y su aplicacion terapeutica DOP2012000001A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903270A FR2947546B1 (fr) 2009-07-03 2009-07-03 Derives de pyrazoles, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
DOP2012000001A true DOP2012000001A (es) 2012-01-31

Family

ID=41695643

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2012000001A DOP2012000001A (es) 2009-07-03 2012-01-02 Derivados de pirazoles, su preparacion y su aplicacion terapeutica

Country Status (30)

Country Link
US (1) US8367715B2 (es)
EP (1) EP2448924B1 (es)
JP (1) JP5680640B2 (es)
KR (1) KR20120037967A (es)
CN (1) CN102471280B (es)
AR (1) AR077371A1 (es)
AU (1) AU2010267824A1 (es)
BR (1) BR112012000104A2 (es)
CA (1) CA2767096A1 (es)
CL (1) CL2012000013A1 (es)
CO (1) CO6480992A2 (es)
CR (1) CR20110701A (es)
DO (1) DOP2012000001A (es)
EA (1) EA020364B1 (es)
EC (2) ECSP12011569A (es)
FR (1) FR2947546B1 (es)
IL (1) IL217300A0 (es)
MA (1) MA33500B1 (es)
MX (1) MX2012000267A (es)
MY (1) MY155829A (es)
NI (1) NI201200001A (es)
NZ (1) NZ597578A (es)
PE (1) PE20120917A1 (es)
SG (1) SG177463A1 (es)
TN (1) TN2011000658A1 (es)
TW (1) TWI471312B (es)
UA (1) UA106500C2 (es)
UY (1) UY32757A (es)
WO (1) WO2011001122A2 (es)
ZA (1) ZA201200027B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908409B1 (fr) * 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
AU2013208104B2 (en) * 2012-01-09 2017-11-23 X-Chem, Inc. Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof
AR094812A1 (es) 2013-02-20 2015-08-26 Eisai R&D Man Co Ltd Derivado de piridina monocíclico como inhibidor del fgfr
MX369646B (es) 2014-08-18 2019-11-15 Eisai R&D Man Co Ltd Sal de derivado de piridina monociclico y su cristal.
AU2016237222B2 (en) 2015-03-25 2021-04-29 Eisai R&D Management Co., Ltd. Therapeutic agent for bile duct cancer
CA3001969C (en) 2015-12-17 2023-10-03 Eisai R&D Management Co., Ltd. Therapeutic agent for breast cancer
CN107619388A (zh) 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用
JPWO2019189241A1 (ja) 2018-03-28 2021-03-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 肝細胞癌治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331541B1 (en) * 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
GB0317127D0 (en) * 2003-07-22 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
US20080161355A1 (en) * 2005-01-21 2008-07-03 Astex Therapeutics Limited Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents
KR101461680B1 (ko) * 2005-12-02 2014-11-19 바이엘 헬스케어 엘엘씨 과다-증식성 장애 및 맥관형성과 관련된 질환의 치료에유용한 치환된 4-아미노-피롤로트리아진 유도체
EP1959947A2 (en) * 2005-12-15 2008-08-27 Cytokinetics, Inc. Certain chemical entities, compositions and methods
US20070208000A1 (en) * 2005-12-15 2007-09-06 Morgan Bradley P Certain chemical entities, compositions and methods
FR2908409B1 (fr) * 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
BRPI0720059A2 (pt) * 2006-12-11 2013-12-17 Irm Llc Compostos e composições como inibidores de cinase

Also Published As

Publication number Publication date
ZA201200027B (en) 2013-03-27
US8367715B2 (en) 2013-02-05
SG177463A1 (en) 2012-02-28
CO6480992A2 (es) 2012-07-16
CL2012000013A1 (es) 2012-09-14
UY32757A (es) 2011-01-31
JP5680640B2 (ja) 2015-03-04
UA106500C2 (uk) 2014-09-10
US20120270918A1 (en) 2012-10-25
IL217300A0 (en) 2012-02-29
CN102471280B (zh) 2014-08-06
TN2011000658A1 (fr) 2013-05-24
WO2011001122A2 (fr) 2011-01-06
JP2012531466A (ja) 2012-12-10
BR112012000104A2 (pt) 2016-03-15
FR2947546A1 (fr) 2011-01-07
AU2010267824A1 (en) 2012-02-16
KR20120037967A (ko) 2012-04-20
HK1169387A1 (en) 2013-01-25
AR077371A1 (es) 2011-08-24
ECSP12011569A (es) 2012-02-29
TWI471312B (zh) 2015-02-01
MA33500B1 (fr) 2012-08-01
EA020364B1 (ru) 2014-10-30
PE20120917A1 (es) 2012-08-17
EA201270128A1 (ru) 2012-07-30
NZ597578A (en) 2013-11-29
CA2767096A1 (fr) 2011-01-06
EP2448924B1 (fr) 2013-09-04
TW201107298A (en) 2011-03-01
CN102471280A (zh) 2012-05-23
MX2012000267A (es) 2012-04-30
NI201200001A (es) 2012-03-30
ECSP12011659A (es) 2012-03-30
FR2947546B1 (fr) 2011-07-01
EP2448924A2 (fr) 2012-05-09
WO2011001122A3 (fr) 2011-02-24
MY155829A (en) 2015-12-15
CR20110701A (es) 2012-03-06

Similar Documents

Publication Publication Date Title
NI201200001A (es) Derivados de pirazoles, su preparación y su aplicación terapéutica.
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
NI201000005A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico.
UY33735A (es) Compuestos antivirales
JO3450B1 (ar) أشكال جرعات تحرير جديدة معدلة لمثبطات زانثين اوكسيدوريدوكتيز أو مثبطات زانثين اوكسيديز
NI200800207A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina
CR11746A (es) Derivados de acido ciclopentanocarboxilico condensados sustituidos con acilamino y su uso como productos farmaceuticos
DOP2011000245A (es) Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapeutica
CR20120261A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
MX2013002948A (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
DK2164532T3 (da) Anvendelse af et hæmoglobin til fremstilling af forbindinger og resulterende forbindinger
WO2012049307A3 (en) Novel n-terminally modified insulin derivatives
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
IN2012DN03379A (es)
CO6501122A2 (es) Nuevos derivados de (heterociclo-piperidina condensada) - (piperazinil)-1-alcanona o de (heterocilco-pirrolidina condensada)-(pieprazinil)-1-alcanona y su utilizacion como inhibidores de p75
FR2941952B1 (fr) Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
CR10969A (es) Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica
ECSP12011971A (es) NUEVOS DERIVADOS (HETEROCICLO-TETRAHIDRO-PIRIDIN)-(PIPERAZINIL)-1-ALCANONA Y (HETEROCICLO-DIHIDRO-PIRROLIDIN)-(PIPERAZINIL)-1-ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75
CY1113835T1 (el) Δραση των εκχυλισματων του φυτου cissampelos pareira εναντι του δαγκειου πυρετου
UY32515A (es) Nuevos derivados anticancerosos de nicotinamida, su preparación y su aplicación terapéutica
UY32516A (es) Derivados anticancerígenos de la nicotinamida, su preparación y su aplicación en terapéutica